YMAB (ymabs.com) Kacepetan wutah bathi saben saham ing taun lumaku
Y-mAbs Therapeutics (YMAB) is retaining key researchers while simultaneously recruiting global distribution experts. Growth is driven by the success of Danyelza, the GD2-SADA platform, and new patents. However, geopolitical tensions are hindering drug exports and international trials. The YoY earnings per share (EPS) trend reflects market expectations, with the metric standing at 9.90, which helps assess earnings adaptability.
Rincian metrik keuangan lan pasar ymabs.com (YMAB)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Y-mAbs Therapeutics|YMAB - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Y-mAbs Therapeutics, Inc.|YMAB - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Y-mAbs Therapeutics, Inc.|YMAB - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Y-mAbs Therapeutics|Rasio jangkoan perantara ymabs.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
YMAB - Penghasilan resik|Bathi resik mangsa ngarep Y-mAbs Therapeutics|YMAB - Pangali P/E|Pangali mangsa ngarep rega marang bathi Y-mAbs Therapeutics|YMAB - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Y-mAbs Therapeutics, Inc.|YMAB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Y-mAbs Therapeutics|YMAB - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan ymabs.com|YMAB - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Y-mAbs Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Pambiji fundamental:Y-mAbs Corp, YMAB
For the biotech sector, where Y-mAbs Therapeutics (YMAB) is implementing innovative radioimmunotherapy for cancer, this indicator serves as a measure of efficiency in transitioning from antibody development to monetization. By analyzing the relative annual growth of net income per share, an investor can see the percentage change in EPS compared to the previous period, allowing for an assessment of the business's actual profitability through the lens of real profit extraction.
Pesaing utama
Kacepetan wutah bathi saben saham ing taun lumaku BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku revmed.com RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki CG Oncology CGON|Wutah bathi saben saham ing taun lumaku UroGen URGN|Prakiraan wutah bathi resik saben saham ing taun iki Bicara Bio (BCAX)|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS - Wutah bathi ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|Aura Bio (AURA) - Wutah bathi ing taun lumaku|CADL (Candel Therapeutics Inc.) - Wutah bathi ing taun lumaku|ARAY: Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki SLS (SELLAS Life Sciences Group, Inc.)|Wutah bathi resik saben siji saham kanggo taun lumaku ACTU|Citius Oncology - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku HURA|TARA: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku Fate Pharma|Aadi Bioscience Inc (WHWK) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku TScan (TCRX)|Wutah bathi resik saben saham ing taun iki CSBR|xbiotech.com (XBIT) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku cel-sci.com (CVM)|OSTX - Kacepetan wutah bathi saben saham ing taun lumaku|Radiopharm Theranostics - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku ARTV|ANL - Wutah bathi saben saham ing taun lumaku|VERU - Wutah bathi ing taun lumaku|Tempest Therapeutics, Inc. (TPST) - Wutah bathi saben saham ing taun lumaku|XLO: Wutah bathi resik saben siji saham kanggo taun lumaku|RENB (Renovaro Biosciences) - Wutah bathi ing taun lumaku|MURA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki KAPA (Kairos Pharma Ltd)|Wutah bathi resik saben siji saham kanggo taun lumaku OKUR|CytoMed Therapeutics Limited - Wutah bathi resik saben saham ing taun iki|CRIS: Wutah bathi saben saham ing taun iki|APLM - Wutah bathi saben saham ing taun lumaku|THAR - Wutah bathi ing taun lumaku|ADVB: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku SBFM|Wutah bathi ing taun lumaku XBIO|Wutah bathi resik saben saham ing taun iki Salarius Pharmaceuticals SLRX|Wutah bathi ing taun lumaku PPBT (Purple Biotech Ltd)|AONC - Wutah bathi resik saben saham ing taun iki|BGNE: Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun iki Checkpoint Therapeutics, Inc CKPT|ELEV: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku iCAD Inc. (ICAD)|IKNA (Ikena) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Notable Labs (NTBL)|Wutah bathi ing taun lumaku VIRX|Wutah bathi resik saben saham ing taun iki MorphoSys Corporation MOR|NAYA Biosciences - Wutah bathi resik saben saham ing taun iki|Owah-owahan bathi resik saben saham ing taun lumaku Ascentage Pharma
